Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy

Molecular Cancer Therapeutics
Barbara Lelj-GarollaMartin Gleave

Abstract

Non-small cell lung cancer (NSCLC) is the most frequent cause of death from cancer worldwide. Despite the availability of active chemotherapy regimens and EGFR tyrosine kinase inhibitors, all advanced patients develop recurrent disease after first-line therapy. Although Hsp27 is a stress-induced chaperone that promotes acquired resistance in several cancers, its relationship to treatment resistance in NSCLC has not been defined. Understanding adaptive responses of acquired resistance will help guide new strategies to control NSCLC. Hsp27 levels were evaluated in an HCC827 erlotinib-resistant-derived cell line (HCC-827Resistant), and sensitivity to erlotinib was examined in Hsp27-overexpressing A549 cells. The role of Hsp27 in both erlotinib and cytotoxic treatment resistance was evaluated in HCC-827 and A549 NSCLC cells using the Hsp27 antisense drug OGX-427. The effect of OGX-427 in combination with erlotinib was also assessed in mice bearing A549 xenografts. Hsp27 is induced by erlotinib and protects NSCLC cells from treatment-induced apoptosis, whereas OGX-427 sensitizes NSCLC cells to erlotinib. Interestingly, increased resistance to erlotinib was observed when Hsp27 was increased either in HCC827 erlotinib-resistant or ove...Continue Reading

References

May 27, 1986·Nucleic Acids Research·E HickeyL A Weber
Jun 17, 1999·International Journal of Cancer. Journal International Du Cancer·H J ArtsA G Van der Zee
Oct 21, 1999·Journal of the National Cancer Institute·L BubendorfO P Kallioniemi
Sep 12, 2000·Nature Cell Biology·J M BrueyC Garrido
Mar 23, 2002·Progress in Molecular and Subcellular Biology·Daniel R Ciocca, Laura M Vargas-Roig
Jan 13, 2004·Biochemical and Biophysical Research Communications·Hui SongJiayuh Lin
Dec 8, 2004·Journal of Molecular Biology·Barbara Lelj-Garolla, A Grant Mauk
Jan 4, 2005·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·María A BauseroAlexzander Asea
May 21, 2005·Nature Reviews. Cancer·Martin E Gleave, Brett P Monia
Jan 27, 2006·The Journal of Biological Chemistry·Barbara Lelj-Garolla, A Grant Mauk
Dec 20, 2007·Cancer Research·Cornelia O'Callaghan-SunolMichael Y Sherman
Aug 1, 2009·Nature Reviews. Drug Discovery·Pixu LiuJean J Zhao
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Dec 18, 2009·Journal of Cellular and Molecular Medicine·Luis Paz-AresBarbara Klughammer
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Feb 26, 2014·Seminars in Oncology·Tony S K MokLinda Leung
Jun 7, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Daniele MusianiMaria Flavia Di Renzo
Aug 15, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ReckUNKNOWN ESMO Guidelines Working Group

❮ Previous
Next ❯

Citations

Aug 25, 2016·Scientific Reports·Sepideh VahidAmina Zoubeidi
Mar 10, 2017·Expert Opinion on Investigational Drugs·Lizza E L Hendriks, Anne-Marie C Dingemans
Sep 16, 2017·International Journal of Molecular Sciences·Suman Chatterjee, Timothy F Burns
Sep 6, 2018·International Journal of Cancer. Journal International Du Cancer·Denise TreueFrederick Klauschen
Dec 30, 2017·Oncotarget·Byeol ChoiYun-Sil Lee
Sep 15, 2016·Oncotarget·Jörg C HeinrichMichael Schroeder
Jan 12, 2017·Cell Stress & Chaperones·Nikolaos CharmpilasNektarios Tavernarakis
Nov 29, 2017·Molecular and Clinical Oncology·Jihad KaramElie Hadchity
Apr 2, 2020·Cancer Biology & Therapy·Sonam Mittal, Maitreyi S Rajala
Dec 18, 2019·The Journal of Clinical Investigation·Lucia NappiMartin Gleave
Sep 16, 2020·International Journal of Molecular Sciences·Jixian XiongLi Fu
Oct 29, 2020·Cell Stress & Chaperones·Daniela CaporossiIvan Dimauro
Feb 11, 2016·Molecular Cancer Therapeutics·Mariangela GarofaloVincenzo Cerullo
Apr 4, 2021·International Journal of Molecular Sciences·Haoyu XiongSarah D Diermeier
May 1, 2021·International Journal of Molecular Sciences·Stéphanie SimonAndré-Patrick Arrigo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Ron FeldLung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Wei ZhangEugene P Frenkel
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Melissa L JohnsonVincent A Miller
© 2022 Meta ULC. All rights reserved